CX Institutional’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.25M Hold
10,365
0.04% 239
2025
Q1
$1.16M Sell
10,365
-174
-2% -$19.4K 0.04% 252
2024
Q4
$1.03M Sell
10,539
-140
-1% -$13.6K 0.04% 254
2024
Q3
$1.23M Buy
10,679
+401
+4% +$46.1K 0.05% 255
2024
Q2
$1.09M Buy
10,278
+76
+0.7% +$8.09K 0.05% 272
2024
Q1
$987K Sell
10,202
-53
-0.5% -$5.13K 0.05% 285
2023
Q4
$1.04M Hold
10,255
0.06% 252
2023
Q3
$1.04M Hold
10,255
0.06% 243
2023
Q2
$1.03M Sell
10,255
-93
-0.9% -$9.39K 0.05% 270
2023
Q1
$957K Buy
10,348
+146
+1% +$13.5K 0.05% 278
2022
Q4
$926K Hold
10,202
0.06% 287
2022
Q3
$775K Hold
10,202
0.05% 295
2022
Q2
$862K Hold
10,202
0.07% 253
2022
Q1
$895K Buy
10,202
+1,375
+16% +$121K 0.07% 228
2021
Q4
$772K Sell
8,827
-1,375
-13% -$120K 0.06% 222
2021
Q3
$834K Hold
10,202
0.07% 221
2021
Q2
$931K Hold
10,202
0.08% 205
2021
Q1
$872K Hold
10,202
0.08% 205
2020
Q4
$963K Sell
10,202
-13
-0.1% -$1.23K 0.09% 190
2020
Q3
$888K Sell
10,215
-31
-0.3% -$2.7K 0.1% 176
2020
Q2
$895K Buy
10,246
+166
+2% +$14.5K 0.12% 153
2020
Q1
$831K Hold
10,080
0.14% 143
2019
Q4
$954K Sell
10,080
-16
-0.2% -$1.51K 0.17% 115
2019
Q3
$877K Sell
10,096
-29
-0.3% -$2.52K 0.14% 139
2019
Q2
$925K Sell
10,125
-1,474
-13% -$135K 0.15% 133
2019
Q1
$999K Buy
11,599
+364
+3% +$31.4K 0.18% 129
2018
Q4
$864K Buy
+11,235
New +$864K 0.18% 96